» Articles » PMID: 11403104

High Prevalence of Vitamin D Deficiency in Japanese Female Patients with Graves' Disease

Overview
Journal Endocr J
Specialty Endocrinology
Date 2001 Jun 14
PMID 11403104
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

We reported previously that vitamin D deficiency is a causal mechanism of postoperative tetany in patients with Graves' disease. The aim of the present study was to determine the prevalence of vitamin D deficiency by reviewing serum 25(OH)D levels in 208 patients with Graves' disease (146 women, 62 men) during a 1 year period. Serum 25(OH)D levels were significantly lower (p < 0.001) in female Graves' patients (31.8 +/- 13.3 nmol/l) than in male patients (41.3 +/- 15.0 nmol/l). Vitamin D deficiency (defined as a serum 25(OH)D value below 25 nmol/l) was found in 40% of female patients and in 18% of male patients (p < 0.005). There was a significant seasonal variation in the 25(OH)D concentrations in female patients [amplitude 6.38 (95% CI, 5.42-7.56)], with values below 25 nmol/l found in 58% of female patients during the winter months. There were significant (p < 0.001) differences in serum 25(OH)D levels between age groups in the female patients. The concentrations were lowest in patients in their twenties (25.1 +/- 8.2 nmol/l) and highest in patients in their fifties and sixties (43.2 +/- 13.7 nmol/l). Serum 25(OH)D concentrations might be monitored in patients with Graves' disease during antithyroid drug therapy, and vitamin D and/or calcium supplements are recommended for patients with vitamin D deficiency.

Citing Articles

Vitamin D Levels in Patients with Active and Remission Graves' Disease.

Rattanamusik N, Uitrakul S, Charoenpiriya A Medicines (Basel). 2023; 10(7).

PMID: 37505062 PMC: 10383553. DOI: 10.3390/medicines10070041.


Vitamin D and bone metabolism in Graves' disease: a prospective study.

Khamisi S, Lundqvist M, Rasmusson A, Engstrom B, Karlsson F, Ljunggren O J Endocrinol Invest. 2022; 46(2):425-433.

PMID: 36166168 PMC: 9859854. DOI: 10.1007/s40618-022-01927-y.


Thyrotoxicosis and osteomalacia: from symptom to pathogenesis.

Du H, Jia A, Gu M, Li S, Zhang P, Bai J Am J Transl Res. 2021; 13(2):803-811.

PMID: 33594328 PMC: 7868833.


Evaluation of Vitamin D Status and its Impact on Thyroid Related Parameters in New Onset Graves' Disease- A Cross-sectional Observational Study.

Mangaraj S, Choudhury A, Swain B, Sarangi P, Mohanty B, Baliarsinha A Indian J Endocrinol Metab. 2019; 23(1):35-39.

PMID: 31016150 PMC: 6446662. DOI: 10.4103/ijem.IJEM_183_18.


Therapy of moderate-to-severe Graves' orbitopathy with intravenous methylprednisolone pulses is not associated with loss of bone mineral density.

Rymuza J, Popow M, Zurecka Z, Przedlacki J, Bednarczuk T, Miskiewicz P Endocrine. 2018; 64(2):308-315.

PMID: 30506426 PMC: 6531386. DOI: 10.1007/s12020-018-1823-x.